Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Yarchoan, R' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 109 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Blazevic, V; Jankelevich, S; Steinberg, SM; Jacobsen, F; Yarchoan, R; Shearer, GM
      Highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: Analysis of cellular immune responses

      CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
    2. Polis, MA; Sidorov, IA; Yoder, C; Jankelevich, S; Metcalf, J; Mueller, BU; Dimitrov, MA; Pizzo, P; Yarchoan, R; Dimitrov, DS
      Correlation between reduction in plasma HIV-1 RNA concentration 1 week after start of antiretroviral treatment and longer-term efficacy

      LANCET
    3. Paulose-Murphy, M; Ha, NK; Xiang, CS; Chen, YD; Gillim, L; Yarchoan, R; Meltzer, P; Bittner, M; Trent, J; Zeichner, S
      Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus)

      JOURNAL OF VIROLOGY
    4. Chougnet, C; Jankelevich, S; Fowke, K; Liewehr, D; Steinberg, SM; Mueller, BU; Pizzo, PA; Yarchoan, R; Shearer, GM
      Long-term protease inhibitor-containing therapy results in limited improvement in T cell function but not restoration of interleukin-12 production inpediatric patients with AIDS

      JOURNAL OF INFECTIOUS DISEASES
    5. Jankelevich, S; Mueller, BU; Mackall, CL; Smith, S; Zwerski, S; Wood, LV; Zeichner, SL; Serchuck, L; Steinberg, SM; Nelson, RP; Sleasman, JW; Nguyen, BY; Pizzo, PA; Yarchoan, R
      Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine

      JOURNAL OF INFECTIOUS DISEASES
    6. Zoeteweij, JP; Moses, AV; Rinderknecht, AS; Davis, DA; Overwijk, WW; Yarchoan, R; Orenstein, JM; Blauvelt, A
      Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus

      BLOOD
    7. Aoki, Y; Yarchoan, R; Wyvill, K; Okamoto, S; Little, RF; Tosato, G
      Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders

      BLOOD
    8. Fry, TJ; Connick, E; Falloon, J; Lederman, MM; Liewehr, DJ; Spritzler, J; Steinberg, SM; Wood, LV; Yarchoan, R; Zuckerman, J; Landay, A; Mackall, CL
      A potential role for interleukin-7 in T-cell homeostasis

      BLOOD
    9. Davis, DA; Rinderknecht, AS; Zoeteweij, JP; Aoki, Y; Read-Connole, EL; Tosato, G; Blauvelt, A; Yarchoan, R
      Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus

      BLOOD
    10. Dai, F; Kelley, JA; Zhang, HP; Malinowski, N; Kavlick, MF; Lietzau, J; Welles, L; Yarchoan, R; Ford, H
      Fluorometric determination of 2 '-beta-fluoro-2 ',3 '-dideoxyadenosine 5 '-triphosphate, the active metabolite of a new anti-human immunodeficiency virus drug, in human lymphocytes

      ANALYTICAL BIOCHEMISTRY
    11. Little, RF; Yarchoan, R; Wilson, WH
      Systemic chemotherapy for HIV-associated lymphoma in the era of highly active antiretroviral therapy

      CURRENT OPINION IN ONCOLOGY
    12. Yarchoan, R
      AIDS-related Kaposi's sarcoma: Current treatment options, future trends

      ONCOLOGY-NEW YORK
    13. Little, RF; Wyvill, KM; Pluda, JM; Welles, L; Marshall, V; Figg, WD; Newcomb, FM; Tosato, G; Feigal, E; Steinberg, SM; Whitby, D; Goedert, JJ; Yarchoan, R
      Activity of thalidomide in AIDS-related Kaposis's sarcoma

      JOURNAL OF CLINICAL ONCOLOGY
    14. Carr, A; Yarchoan, R
      Clinical treatment

      AIDS
    15. Davis, DA; Newcomb, FM; Moskovitz, J; Wingfield, PT; Stahl, SJ; Kaufman, J; Fales, HM; Levine, RL; Yarchoan, R
      HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase

      BIOCHEMICAL JOURNAL
    16. Cocchi, F; DeVico, AL; Yarchoan, R; Redfield, R; Cleghorn, F; Blattner, WA; Garzino-Demo, A; Colombino-Hatch, S; Margolis, D; Gallo, RC
      Higher macrophage inflammatory protein (MIP)-1 alpha and MIP-1 beta levelsfrom CD8(+) T cells are associated with asymptomatic HIV-1 infection

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    17. Sgadari, C; Toschi, E; Palladino, C; Barillari, G; Carlei, D; Cereseto, A; Ciccolella, C; Yarchoan, R; Monini, P; Sturzl, M; Ensoli, B
      Mechanism of paclitaxel activity in Kaposi's sarcoma

      JOURNAL OF IMMUNOLOGY
    18. Foster, CB; Lehmbecher, T; Samuels, S; Stein, S; Mol, F; Metcalf, JA; Wyvill, K; Steinberg, SM; Kovacs, J; Blauvelt, A; Yarchoan, R; Chanock, SJ
      An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus

      BLOOD
    19. Aoki, Y; Yarchoan, R; Braun, J; Iwamoto, A; Tosato, G
      Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions

      BLOOD
    20. Lehrnbecher, T; Foster, CB; Zhu, SX; Venzon, D; Steinberg, SM; Wyvill, K; Metcalf, JA; Cohen, SS; Kovacs, J; Yarchoan, R; Blauvelt, A; Chanock, SJ
      Variant genotypes of Fc gamma RIIIA influence the development of Kaposi's sarcoma in HIV-infected men

      BLOOD
    21. Aokl, Y; Tosato, G; Nambu, Y; Iwamoto, A; Yarchoan, R
      Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas

      BLOOD
    22. Little, RF; Yarchoan, R
      Considerations in the management of HIV infection in patients undergoing antineoplastic chemotherapy

      AIDS-RELATED CANCERS AND THEIR TREATMENT
    23. Yarchoan, R
      Therapy for Kaposi's sarcoma: Recent advances and experimental approaches

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY
    24. Grossman, Z; Polis, M; Feinberg, MB; Grossman, Z; Levi, I; Jankelevich, S; Yarchoan, R; Boon, J; de Wolf, F; Lange, JMA; Goudsmit, J; Dimitrov, DS; Paul, WE
      Ongoing HIV dissemination during HAART

      NATURE MEDICINE
    25. Pinto, LA; Berzofsky, JA; Fowke, KR; Little, RF; Merced-Galindez, F; Humphrey, R; Ahlers, J; Dunlop, N; Cohen, RB; Steinberg, SM; Nara, P; Shearer, GM; Yarchoan, R
      HIV-specific immunity following immunization with HIV synthetic envelope peptides in asymptomatic HIV-infected patients

      AIDS
    26. Yarchoan, R; Vella, S
      Clinical treatment

      AIDS
    27. Humphrey, RW; Wyvill, KM; Nguyen, BY; Shay, LE; Kohler, DR; Steinberg, SM; Ueno, T; Fukasawa, T; Shintani, M; Hayashi, H; Mitsuya, H; Yarchoan, R
      A phase I trial of the pharmacokinetics, toxicity, and activity of KNI-272, an inhibitor of HIV-1 protease, in patients with AIDS or symptomatic HIV infection

      ANTIVIRAL RESEARCH
    28. Davis, DA; Yusa, K; Gillim, LA; Newcomb, FM; Mitsuya, H; Yarchoan, R
      Conserved cysteines of the human immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions

      JOURNAL OF VIROLOGY
    29. Jones, KD; Aoki, Y; Chang, Y; Moore, PS; Yarchoan, R; Tosato, G
      Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells

      BLOOD
    30. Monini, P; Colombini, S; Sturzl, M; Goletti, D; Cafaro, A; Sgadari, C; Butto, S; Franco, M; Leone, P; Fais, S; Leone, P; Melucci-Vigo, G; Chiozzini, C; Carlini, F; Ascherl, G; Cornali, E; Zietz, C; Ramazzotti, E; Ensoli, F; Andreoni, W; Pezzotti, P; Rezza, G; Yarchoan, R; Gallo, RC; Ensoli, B
      Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma

      BLOOD
    31. HUMPHREY RW; DAVIS DA; NEWCOMB FM; YARCHOAN R
      HUMAN-HERPESVIRUS-8 (HHV-8) IN THE PATHOGENESIS OF KAPOSIS-SARCOMA AND OTHER DISEASES

      Leukemia & lymphoma
    32. DAVIS DA; NEWCOMB FM; MOSKOVITZ J; WINGFIELD PT; KAUFMANN J; STAHL SJ; FALES HM; LEVINE RL; YARCHOAN R
      INACTIVATION OF HIV-1 AND HIV-2 PROTEASES THROUGH OXIDATIVE MODIFICATION

      Free radical biology & medicine
    33. LITTLE RF; PLUDA JM; FEIGAL E; YARCHOAN R
      THE CHALLENGE OF DESIGNING CLINICAL-TRIALS FOR AIDS-RELATED KAPOSIS-SARCOMA

      Oncology
    34. WELLES L; SAVILLE MW; LIETZAU J; PLUDA JM; WYVILL KM; FEUERSTEIN I; FIGG WD; LUSH R; ODOM J; WILSON WH; FAJARDO MT; HUMPHREY RW; FEIGAL E; TUCK D; STEINBERG SM; BRODER S; YARCHOAN R
      PHASE-II TRIAL WITH DOSE TITRATION OF PACLITAXEL FOR THE THERAPY OF HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSIS-SARCOMA

      Journal of clinical oncology
    35. NGUYEN BY; CLERICI M; VENZON DJ; BAUZA S; MURPHY WJ; LONGO DL; BASELER M; GESUNDHEIT N; BRODER S; SHEARER G; YARCHOAN R
      PILOT-STUDY OF THE IMMUNOLOGICAL EFFECTS OF RECOMBINANT HUMAN GROWTH-HORMONE AND RECOMBINANT INSULIN-LIKE-GROWTH-FACTOR IN HIV-INFECTED PATIENTS

      AIDS
    36. WILLIAMS SB; SANO M; SMITH N; HORNE M; YARCHOAN R; WYVILL K; ZEICHNER S; TAYLOR P; KNUDSON T; GRALNICK HR
      GLYCOCALICIN LEVELS IN THE PLASMA OF HIV- AN INDICATOR OF PLATELET TURNOVER( PATIENTS )

      The Journal of laboratory and clinical medicine
    37. PERNO CF; NEWCOMB FM; DAVIS DA; AQUARO S; HUMPHREY RW; CALIO R; YARCHOAN R
      RELATIVE POTENCY OF PROTEASE INHIBITORS IN MONOCYTES MACROPHAGES ACUTELY AND CHRONICALLY INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS/

      The Journal of infectious diseases
    38. KAVLICK MF; WYVILL K; YARCHOAN R; MITSUYA H
      EMERGENCE OF MULTI-DIDEOXYNUCLEOSIDE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS, VIRAL SEQUENCE VARIATION, AND DISEASE PROGRESSION IN PATIENTS RECEIVING ANTIRETROVIRAL CHEMOTHERAPY

      The Journal of infectious diseases
    39. YARCHOAN R; JAFFE ES; LITTLE R
      DIAGNOSING CENTRAL-NERVOUS-SYSTEM LYMPHOMA IN THE SETTING OF AIDS - ASTEP FORWARD

      Journal of the National Cancer Institute
    40. YARCHOAN R; LITTLE R
      OPTIMIZING COMBINATION CHEMOTHERAPY FOR KAPOSIS-SARCOMA

      The cancer journal from Scientific American
    41. PLUDA JM; WYVILL KK; LIETZAU J; FIGG WD; WHITCUP SM; FEIGAL E; HUMPHREY R; WELLES L; YARCHOAN R
      A PHASE-I TRIAL ADMINISTERING THE ANGIOGENESIS INHIBITOR TNP-470 (AGM-1470) TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS)

      Journal of acquired immune deficiency syndromes and human retrovirology
    42. WELLES L; LITTLE R; WYVILL K; PLUDA J; FIGG W; LIETZAU J; MERCED T; HUMPHREY R; YARCHOAN R
      PRELIMINARY-RESULTS OF A PHASE-II STUDY OF ORAL THALIDOMIDE IN PATIENTS WITH HIV-INFECTION AND KAPOSIS-SARCOMA (KS)

      Journal of acquired immune deficiency syndromes and human retrovirology
    43. FEIGAL EG; VONROENN J; JUSTICE R; YARCHOAN R; KROWN S; PLUDA J; ARBUCK S; MURGO A; MCCABE M; UNGERLEIDER R; WITTES R
      KAPOSIS-SARCOMA RESPONSE CRITERIA - ISSUES IDENTIFIED BY THE NATIONAL-CANCER-INSTITUTE, FOOD-AND-DRUG-ADMINISTRATION, AND THE AIDS-MALIGNANCY-CONSORTIUM

      Journal of acquired immune deficiency syndromes and human retrovirology
    44. COLOMBINIHATCH S; TRWNISZEWSKA E; RAMAZZONI E; RIVARDENEIRA E; YARCHOAN R; HUMPHREY R; ENSOLI B; GALLO RC
      ISOLATION OF HUMAN HERPESVIRUS-8 (HHV-8) FROM PBMC OF AIDS-KS PATIENTS AND VIRAL TRANSMISSION TO PRIMARY-CELL CULTURE

      Journal of acquired immune deficiency syndromes and human retrovirology
    45. HUMPHREY RW; DAVIS DA; NEWCOMB FM; OBRIEN TR; GOEDERT JJ; STRAUS SE; PASS R; YARCHOAN R
      ANALYSIS OF HUMAN HERPESVIRUS-8 INFECTION IN CHILDREN AND ADULTS BY MEASURING SERUM ANTIBODIES TO A PEPTIDE OF A MINOR CAPSID PROTEIN OR BYPCR

      Journal of acquired immune deficiency syndromes and human retrovirology
    46. LITTLE R; FRANCHINI G; PEARSON D; ELWOOD P; STEINBERG S; YARCHOAN R; WILSON WH
      HIV VIRAL BURDEN (VB) DURING EPOCH CHEMOTHERAPY (CT) FOR HIV-RELATED LYMPHOMAS

      Journal of acquired immune deficiency syndromes and human retrovirology
    47. DAVIS DA; NEWCOMB FM; STARKE DW; OTT DE; MIEYAL JJ; YARCHOAN R
      GLUTATHIONYLATED FORMS OF THE HIV-1 PROTEASE ARE SUBSTRATES FOR HUMANTHIOLTRANSFERASE (GLUTAREDOXIN), AN ENZYME ALSO DETECTED IN HIV-1 VIRIONS

      The FASEB journal
    48. FOLI A; SAVILLE MW; MAY LT; WEBB DSA; YARCHOAN R
      EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS AND COLONY-STIMULATING FACTORS ON THE PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA BY MONOCYTE MACROPHAGES/

      AIDS research and human retroviruses
    49. FIGG WD; PLUDA JM; LUSH RM; SAVILLE MW; WYVILL K; REED E; YARCHOAN R
      THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR

      Pharmacotherapy
    50. BROUWERS P; HENDRICKS M; LIETZAU JA; PLUDA JM; MITSUYA H; BRODER S; YARCHOAN R
      EFFECT OF COMBINATION THERAPY WITH ZIDOVUDINE AND DIDANOSINE ON NEUROPSYCHOLOGICAL FUNCTIONING IN PATIENTS WITH SYMPTOMATIC HIV DISEASE - ACOMPARISON OF SIMULTANEOUS AND ALTERNATING REGIMENS

      AIDS
    51. HUMPHREY RW; OHAGEN A; DAVIS DA; FUKAZAWA T; HAYASHI H; HOGLUND S; MITSUYA H; YARCHOAN R
      REMOVAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) PROTEASE INHIBITORS FROM PREPARATIONS OF IMMATURE HIV-1 VIRIONS DOES NOT RESULT IN AN INCREASE IN INFECTIVITY OR THE APPEARANCE OF MATURE MORPHOLOGY

      Antimicrobial agents and chemotherapy
    52. DAVIS DA; HUMPHREY RW; NEWCOMB FM; OBRIEN TR; GOEDERT JJ; STRAUS SE; YARCHOAN R
      DETECTION OF SERUM ANTIBODIES TO A KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-SPECIFIC PEPTIDE

      The Journal of infectious diseases
    53. BLAUVELT A; ASADA H; SAVILLE MW; KLAUSKOVTUN V; ALTMAN DJ; YARCHOAN R; KATZ SI
      PRODUCTIVE INFECTION OF DENDRITIC CELLS BY HIV-1 AND THEIR ABILITY TOCAPTURE VIRUS ARE MEDIATED THROUGH SEPARATE PATHWAYS

      The Journal of clinical investigation
    54. DAVIS DA; NEWCOMB FM; STARKE DW; OTT DE; MIEYAL JJ; YARCHOAN R
      THIOLTRANSFERASE (GLUTAREDOXIN) IS DETECTED-WITHIN HIV-1 AND CAN REGULATE THE ACTIVITY OF GLUTATHIONYLATED HIV-1 PROTEASE IN-VITRO

      The Journal of biological chemistry
    55. HUMPHREY RW; DAVIS DA; MITSUYA H; YARCHOAN R
      HIV VIRIONS PRODUCED BY CELLS TREATED WITH THE HIV-1 PROTEASE INHIBITOR KNI-272 DO NOT ACQUIRE INFECTIVITY AFTER VIRAL BUDDING

      Journal of investigative medicine
    56. KARP JE; PLUDA JM; YARCHOAN R
      AIDS-RELATED KAPOSIS-SARCOMA - A TEMPLATE FOR THE TRANSLATION OF MOLECULAR PATHOGENESIS AND TARGETED THERAPEUTIC APPROACHES

      Hematology/oncology clinics of North America
    57. FOLI A; SOGOCIO KM; ANDERSON B; KAVLICK M; SAVILLE MW; WAINBERG MA; GU ZX; CHERRINGTON JM; MITSUYA H; YARCHOAN R
      IN-VITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH REDUCED SENSITIVITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA)

      Antiviral research
    58. BLAUVELT A; SAVILLE MW; ASADA H; KLAUSKOVTUN V; ALTMAN DJ; YARCHOAN R; KATZ SI
      PRODUCTIVE INFECTION OF LANGERHANS CELL-LIKE DENDRITIC CELLS BY HIV AND THEIR ABILITY TO CAPTURE VIRUS ARE MEDIATED THROUGH SEPARATE PATHWAYS

      Journal of investigative dermatology
    59. STEFANOVA I; SAVILLE MW; PETERS C; CLEGHORN FR; SCHWARTZ D; VENZON DJ; WEINHOLD KJ; JACK N; BARTHOLOMEW C; BLATTNER WA; YARCHOAN R; BOLEN JB; HORAK ID
      HIV INFECTION-INDUCED POSTTRANSLATIONAL MODIFICATION OF T-CELL SIGNALING MOLECULES ASSOCIATED WITH DISEASE PROGRESSION

      The Journal of clinical investigation
    60. HUMPHREY RW; OBRIEN TR; NEWCOMB FM; NISHIHARA H; WYVILL KM; RAMOS GA; SAVILLE MW; GOEDERT JJ; STRAUS SE; YARCHOAN R
      KAPOSIS-SARCOMA (KS)-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - ASSOCIATION WITH KS AND PERSISTENCE IN PATIENTS RECEIVING ANTI-HERPESVIRUS DRUGS

      Blood
    61. SAVILLE MW; LIETZAU J; PLUDA JM; WILSON W; FEIGAL E; FEUERSTEIN I; ODOM J; HUMPHREY R; BRODER S; YARCHOAN R
      ACTIVITY OF PACLITAXEL (TAXOL(TM)) FOR THE TREATMENT OF HIV-ASSOCIATED KAPOSIS SARCOMA (KS)

      AIDS research and human retroviruses
    62. HUMPHREY RW; NISHIHARA H; SAVILLE MW; STRAUS SE; YARCHOAN R
      DETECTION OF KAPOSIS-SARCOMA-ASSOCIATED HERPES-VIRUS (KSHV) DNA-SEQUENCES IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS (PBMC) OBTAINED FROM HIV KAPOSIS-SARCOMA (KS) PATIENTS WITHOUT AND DURING THERAPY

      AIDS research and human retroviruses
    63. BLAUVELT A; SAVILLE MW; ASADA H; KLAUSKOVTUN V; YARCHOAN R; KATZ SI
      CULTURED DENDRITIC CELLS CAN BE INFECTED WITH HIV AND CAN EFFICIENTLYTRANSFER HIV TO CD4-CELLS DURING THE GENERATION OF IMMUNE-RESPONSES( T)

      AIDS research and human retroviruses
    64. HUMPHREY RW; SAVILLE MW; MITSUYA H; YARCHOAN R
      HIV-1 PROTEASE FUNCTION PRIOR TO VIRAL BUDDING IS ESSENTIAL FOR THE PRODUCTION OF INFECTIOUS VIRIONS

      AIDS research and human retroviruses
    65. NGUYEN BY; CLERICI M; BAUZA S; BAILEY J; LONGO D; MURPHY W; GESUNDHEIT N; VENZON D; SHEARER G; YARCHOAN R
      IMMUNOLOGICAL EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH-FACTOR(RHIGF-1) AND RECOMBINANT HUMAN GROWTH-HORMONE (RHGH) IN HIV-INFECTEDPATIENTS

      AIDS research and human retroviruses
    66. SOGOCIO KM; ANDERSON B; KAVLICK M; SAVILLE W; WAINBERG MA; CHERRINGTON JM; MITSUYA H; YARCHOAN R
      HIV-1 DEVELOPS REDUCED SENSITIVITY TO 9-(2-PHOSPHONYLMETHOXYETHYL) ADENINE (PMEA) IN-VITRO THROUGH ACQUISITION OF K65R

      AIDS research and human retroviruses
    67. BAILEY J; PLUDA JM; FOLI A; SAVILLE MW; BAUZA S; ADAMSON PC; MURPHY RF; COHEN RB; BRODER S; YARCHOAN R
      PHASE I II STUDY OF INTERMITTENT ALL-TRANS-RETINOIC ACID, ALONE AND IN COMBINATION WITH INTERFERON ALFA-2A, IN PATIENTS WITH EPIDEMIC KAPOSIS-SARCOMA/

      Journal of clinical oncology
    68. ADAMSON PC; BAILEY J; PLUDA J; POPLACK DG; BAUZA S; MURPHY RF; YARCHOAN R; BALIS FM
      PHARMACOKINETICS OF ALL-TRANS-RETINOIC ACID ADMINISTERED ON AN INTERMITTENT SCHEDULE

      Journal of clinical oncology
    69. KAVLICK MF; SHIRASAKA T; KOJIMA E; PLUDA JM; HUI F; YARCHOAN R; MITSUYA H
      GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF HIV-1 ISOLATED FROM PATIENTS RECEIVING (-)-2',3'-DIDEOXY-3'-THIACYTIDINE

      Antiviral research
    70. SAVILLE MW; LIETZAU J; PLUDA JM; FEUERSTEIN I; ODOM J; WILSON WH; HUMPHREY RW; FEIGAL E; STEINBERG SM; BRODER S; YARCHOAN R
      TREATMENT OF HIV-ASSOCIATED KAPOSIS-SARCOMA WITH PACLITAXEL

      Lancet
    71. GU ZX; SALOMON H; CHERRINGTON JM; MULATO AS; CHEN MS; YARCHOAN R; FOLI A; SOGOCIO KM; WAINBERG MA
      K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE

      Antimicrobial agents and chemotherapy
    72. YANG YL; BAILEY J; VACCHIO MS; YARCHOAN R; ASHWELL JD
      RETINOIC ACID INHIBITION OF EX-VIVO HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED APOPTOSIS OF PERIPHERAL-BLOOD CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    73. SHIRASAKA T; KAVLICK MF; UENO T; GAO WY; KOJIMA E; ALCAIDE ML; CHOKEKIJCHAI S; ROY BM; ARNOLD E; YARCHOAN R; MITSUYA H
      EMERGENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH RESISTANCE TO MULTIPLE DIDEOXYNUCLEOSIDES IN PATIENTS RECEIVING THERAPY WITHDIDEOXYNUCLEOSIDES

      Proceedings of the National Academy of Sciences of the United Statesof America
    74. PLUDA JM; COOLEY TP; MONTANER JSG; SHAY LE; REINHALTER NE; WARTHAN SN; RUEDY J; HIRST HM; VICARY CA; QUINN JB; YUEN GJ; WAINBERG MA; RUBIN M; YARCHOAN R
      A PHASE I II STUDY OF 2'-DEOXY-3'-THIACYTIDINE (LAMIVUDINE) IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION/

      The Journal of infectious diseases
    75. KOJIMA E; SHIRASAKA T; ANDERSON BD; CHOKEKIJCHAI S; STEINBERG SM; BRODER S; YARCHOAN R; MITSUYA H
      HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) VIREMIA CHANGES AND DEVELOPMENT OF DRUG-RELATED MUTATIONS IN PATIENTS WITH SYMPTOMATIC HIV-1 INFECTION RECEIVING ALTERNATING OR SIMULTANEOUS ZIDOVUDINE AND DIDANOSINE THERAPY

      The Journal of infectious diseases
    76. NGUYEN BY; YARCHOAN R; WYVILL KM; VENZON DJ; PLUDA JM; MITSUYA H; BRODER S
      5-YEAR FOLLOW-UP OF A PHASE-I STUDY OF DIDANOSINE IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      The Journal of infectious diseases
    77. BLAUVELT A; CLERICI M; LUCEY DR; STEINBERG SM; YARCHOAN R; WALKER R; SHEARER GM; KATZ SI
      FUNCTIONAL-STUDIES OF EPIDERMAL LANGERHANS CELLS AND BLOOD MONOCYTES IN HIV-INFECTED PERSONS

      The Journal of immunology
    78. FOLI BA; SAVILLE MW; BASELER MW; YARCHOAN R
      EFFECTS OF THE TH-1 AND TH-2 STIMULATORY CYTOKINES INTERLEUKIN-12 ANDINTERLEUKIN-4 ON HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION

      Blood
    79. DAVIS DA; BRANCA AA; PALLENBERG AJ; MARSCHNER TM; PATT LM; CHATLYNNE LG; HUMPHREY RW; YARCHOAN R; LEVINE RL
      INHIBITION OF THE HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE AND HUMAN IMMUNODEFICIENCY VIRUS-1 REPLICATION BY BATHOCUPROINE DISULFONIC ACID CU1+

      Archives of biochemistry and biophysics
    80. FIGG WD; YEH HJC; THIBAULT A; PLUDA JM; ITOH F; YARCHOAN R; COOPER MR
      ASSAY OF THE ANTIANGIOGENIC COMPOUND TNP-470, AND ONE OF ITS METABOLITES, AGM-1883, BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY IN PLASMA

      Journal of chromatography B. Biomedical applications
    81. SAVILLE MW; TOSATO G; TAGA K; FOLI A; BRODER S; YARCHOAN R
      INHIBITION OF HIV REPLICATION IN MONOCYTE MACROPHAGES (M/M) BY INTERLEUKIN-10/

      AIDS research and human retroviruses
    82. BROWNING PJ; SECHLER JMG; ENSOLI B; KAPLAN M; WASHINGTON RH; GENDELMAN R; YARCHOAN R; GALLO RC
      IDENTIFICATION AND CULTURE OF KS-LIKE SPINDLE CELLS FROM THE PERIPHERAL-BLOOD OF HIV-1-INFECTED INDIVIDUALS AND NORMAL CONTROLS

      AIDS research and human retroviruses
    83. YARCHOAN R; SAVILLE MW; PLUDA JM; FOLI A; BAILEY J; WILSON W; BRODER S
      APPROACHES TO THE DEVELOPMENT OF THERAPY FOR KAPOSISS SARCOMA (KS) - A REPORT ON ONGOING STUDIES

      AIDS research and human retroviruses
    84. FOLI A; SAVILLE MW; YARCHOAN R
      MECHANISMS FOR THE OVERPRODUCTION OF INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HIV-INFECTION

      AIDS research and human retroviruses
    85. KOJIMA E; SHIRASAKA T; ANDERSON B; CHOKEKIJCHAI S; YARCHOAN R; MITSUYA H
      ANTI-HIV THERAPY AND MONITORING ITS EFFECT USING POLYMERASE CHAIN-REACTION

      AIDS research and human retroviruses
    86. ANDERSON BD; SHIRASAKA T; KOJIMA E; YARCHOAN R; MITSUYA H
      IDENTIFICATION OF DRUG-RELATED GENOTYPIC CHANGES IN HIV-1 FROM SERUM USING THE SELECTIVE POLYMERASE CHAIN-REACTION

      Antiviral research
    87. BLAUVELT A; CLERICI M; LUCEY DR; YARCHOAN R; WALKER R; SHEARER GM; KATZ SI
      ANTIGEN PRESENTATION BY EPIDERMAL LANGERHANS CELLS IN HIV-INFECTED INDIVIDUALS IS NORMAL

      Journal of investigative dermatology
    88. SEI S; KLEINER DE; KOPP JB; CHANDRA R; KLOTMAN PE; YARCHOAN R; PIZZO PA; MITSUYA H
      QUANTITATIVE-ANALYSIS OF VIRAL BURDEN IN TISSUES FROM ADULTS AND CHILDREN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ASSESSED BY POLYMERASE CHAIN-REACTION

      The Journal of infectious diseases
    89. YARCHOAN R; LIETZAU JA; NGUYEN BY
      A RANDOMIZED PILOT-STUDY OF ALTERNATING OR SIMULTANEOUS ZIDOVUDINE AND DIDANOSINE THERAPY IN PATIENTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION (VOL 169, PG 9, 1994)

      The Journal of infectious diseases
    90. YARCHOAN R; LIETZAU JA; NGUYEN BY; BRAWLEY OW; PLUDA JM; SAVILLE MW; WYVILL KM; STEINBERG SM; AGBARIA R; MITSUYA H; BRODER S
      A RANDOMIZED PILOT-STUDY OF ALTERNATING OR SIMULTANEOUS ZIDOVUDINE AND DIDANOSINE THERAPY IN PATIENTS WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      The Journal of infectious diseases
    91. FIGG WD; PLUDA JM; WYVILL K; SAVILLE W; THIBAULT A; MCCALL NA; SOGOCIO T; REED E; BRODER S; YARCHOAN R
      THE PHARMACOKINETICS OF TNP-470, A NEW ANGIOGENESIS INHIBITOR

      Clinical research
    92. KAVLICK MF; KOJIMA E; SHIRASAKA T; PLUDA J; YARCHOAN R; MITSUYA H
      DEVELOPMENT OF 3TC-RESISTANT HIV-1 IN PATIENTS RECEIVING 3TC

      Clinical research
    93. BROWNING PJ; SECHLER JMG; KAPLAN M; WASHINGTON RH; GENDELMAN R; YARCHOAN R; ENSOLI B; GALLO RC
      IDENTIFICATION AND CULTURE OF KAPOSIS SARCOMA-LIKE SPINDLE CELLS FROMTHE PERIPHERAL-BLOOD OF HUMAN IMMUNODEFICIENCY VIRUS-1-INFECTED INDIVIDUALS AND NORMAL CONTROLS

      Blood
    94. SAVILLE MW; LIETZAU J; PLUDA JM; WILSON W; BAILEY J; COHEN R; FEIGAL E; HUMPHREY R; BRODER S; YARCHOAN R
      PHASE-II STUDY OF PACLITAXEL (TAXOL(TM)) FOR THE TREATMENT OF HIV-ASSOCIATED KAPOSIS-SARCOMA (KS)

      Blood
    95. SAVILLE MW; TAGA K; FOLI A; BRODER S; TOSATO G; YARCHOAN R
      INTERLEUKIN-10 SUPPRESSES HUMAN IMMUNODEFICIENCY VIRUS-1 REPLICATION IN-VITRO IN CELLS OF THE MONOCYTE MACROPHAGE LINEAGE/

      Blood
    96. NGUYEN BY; LANDUCCI DL; CUNNION RE; YARCHOAN R; WALKER RE
      A CASE OF HYPERDYNAMIC SHOCK CAUSED BY TRIMETHOPRIM-SULFAMETHOXAZOLE IN WHICH NO TUMOR-NECROSIS-FACTOR OR FEATURES OF ANAPHYLAXIS WERE DETECTED

      Clinical infectious diseases
    97. YARCHOAN R; LIETZAU JA; BRAWLEY O; NGUYEN BY; MITSUYA H; PLUDA JM; WYVILL KM; BRODER S
      THERAPY OF AIDS OR SYMPTOMATIC HIV-INFECTION WITH SIMULTANEOUS OR ALTERNATING REGIMENS OF AZT AND DDI

      Journal of acquired immune deficiency syndromes
    98. CLERICI M; YARCHOAN R; AMMANN AJ; BRODER S; SHEARER GM
      EFFECT OF RECOMBINANT CD4-IGG ON INVITRO HELPER T-CELL FUNCTION - DATA FROM A PHASE I II STUDY OF PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS)/

      Journal of acquired immune deficiency syndromes
    99. PLUDA JM; SHAY LE; FOLI A; COHEN PJ; ADAMO D; BRODER S; YARCHOAN R
      ADMINISTRATION OF PENTOSAN POLYSULFATE TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS)

      Journal of acquired immune deficiency syndromes
    100. FOLI A; YARCHOAN R
      MONOCYTE-MACROPHAGES (M M) PRODUCE INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN RESPONSE TO GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF), BUT NOT TO HIV-INFECTION ALONE/

      Journal of acquired immune deficiency syndromes


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 16:50:00